Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3199 Target Snapshot

Acetylcholinesterase · SINGLE PROTEIN · Rattus norvegicus

1,814Compounds
256Assays
8Approved Drugs
1,940.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P37136. Use UniProt P37136 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P37136 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acetylcholinesterase as ChEMBL target CHEMBL3199, mapped to UniProt P37136. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acetylcholinesterase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3199
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P37136
Acetylcholinesterase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acetylcholinesterase is the right protein anchor across sources, using UniProt P37136 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAcetylcholinesterase
UniProt AccessionP37136
Component TypeProtein
Sequence Length614 aa

Acetylcholinesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acetylcholinesterase, mapped to UniProt P37136. Sequence length is 614 aa.

Mapped IDP37136
Review nameAcetylcholinesterase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

8
Approved
2
Phase III
8
Phase II
Assay Mix

Activity Type Distribution

IC501,920.0
KI18.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL307004 10.15 IC50 0.07 Preclinical
CHEMBL4066593 10.15 IC50 0.07 Preclinical
CHEMBL32823 9.7 IC50 0.2 Preclinical
CHEMBL4080023 9.7 IC50 0.2 Preclinical
CHEMBL312310 9.52 IC50 0.3 Preclinical
CHEMBL340427 9.52 IC50 0.3 Preclinical
CHEMBL4104258 9.52 IC50 0.3 Preclinical
CHEMBL106739 9.42 IC50 0.38 Preclinical
CHEMBL73800 9.4 IC50 0.4 Preclinical
CHEMBL117521 9.4 IC50 0.4 Preclinical
Distribution

pChEMBL Value Distribution

200
5.0
236
5.5
200
6.0
234
6.5
200
7.0
167
7.5
78
8.0
35
8.5
24
9.0
5
9.5
pChEMBL
Approved Drugs

Approved Drugs

NEOSTIGMINE METHYLSULFATE
CHEMBL211471
Approved 2013
GALANTAMINE
CHEMBL659
Approved 2001
DONEPEZIL
CHEMBL502
Approved 1996
TACRINE
CHEMBL95
Approved 1993
TACRINE HYDROCHLORIDE
CHEMBL1677
Approved 1993
Assay Landscape

Assay Landscape

256
Total Assays
1,493
Tested Compounds
3
Assay Types
Binding — 236 assays, 1,493 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 125 887 6.2
tissue-based format 57 317 6.5
single protein format 33 279 6.6
organism-based format 19 0
cell-based format 2 10 4.1
Functional — 15 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 9 1 4.5
organism-based format 6 0
ADME — 5 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 15 4.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine